Implication of TLR- but not of NOD2-signaling pathways in dendritic cell activation by group B streptococcus serotypes III and V

13Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

Abstract

Group B Streptococcus (GBS) is an important agent of life-threatening invasive infection. It has been previously shown that encapsulated type III GBS is easily internalized by dendritic cells (DCs), and that this internalization had an impact on cytokine production. The receptors underlying these processes are poorly characterized. Knowledge on the mechanisms used by type V GBS to activate DCs is minimal. In this work, we investigated the role of Toll-like receptor (TLR)/MyD88 signaling pathway, the particular involvement of TLR2, and that of the intracellular sensing receptor NOD2 in the activation of DCs by types III and V GBS. The role of capsular polysaccharide (CPS, one of the most important GBS virulence factors) in bacterial-DC interactions was evaluated using non-encapsulated mutants. Despite differences in the role of CPS between types III and V GBS in bacterial internalization and intracellular survival, no major differences were observed in their capacity to modulate release of cytokines by DC. For both serotypes, CPS had a minor role in this response. Production of cytokines by DCs was shown to strongly rely on MyD88-dependent signaling pathways, suggesting that DCs recognize GBS and become activated mostly through TLR signaling. Yet, GBS-infected TLR2-/-DCs only showed a partial reduction in the production of IL-6 and CXCL1 compared to control DCs. Surprisingly, CXCL10 release by type III or type V GBS-infected DCs was MyD88-independent. No differences in DC activation were observed between NOD2-/- and control DCs. These results demonstrate the involvement of various receptors and the complexity of the cytokine production pathways activated by GBS upon DC infection.

Figures

  • Table 1. Bacterial strains, plasmids and oligonucleotide primers used in this study.
  • Figure 1. Phagocytosis by and intracellular survival within DCs of type V GBS: role of bacterial capsular polysaccharide. (A) Transmission electron micrographs of GBS strains labeled with polycationic ferritin show GBS wild-type strain CJB111 with a thick capsule (indicated by arrows) whereas no capsular material is observed in DcpsEmutant strain. (B) Growth curves of wild-type GBS strain CJB111 and DcpsEmutant strain. (C) Wild-type type V GBS strain CJB111 or the DcpsE non-encapsulated mutant (106 CFU/ml, initial MOI:1) were incubated with C57BL/6J-derived bmDCs for different time periods. Internalized bacteria were enumerated by quantitative plating after 1 h of antibiotic treatment to kill extracellular bacteria. ** P,0.01, indicates statistically significant differences between the wild-type strain CJB111 and the non-encapsulated mutant, n55. (D) For intracellular survival assays, bmDCs were infected with GBS strains (MOI:1) and phagocytosis was left to proceed for 60 min. Antibiotics (ATB) were then added for 1 h (defined as time 0). This initial antibiotic-treatment was extended up to 5 h and cells lysed to quantify intracellular bacteria by viable plate counting. ** P,0.01, indicates incubation times for which significantly differences in the numbers of recovered intracellular bacteria were observed compared to time 0, n58. All results are expressed as CFU recovered bacteria per ml (means ¡ SEM). It should be noted that initial MOI was the same for all conditions and bacterial growth rate in the culture medium was identical for both strains.
  • Figure 2. Effect of MyD88, TLR2 or NOD2 deficiency on the capacity of DCs to internalize GBS. Control (CTRL), MyD88-/-, TLR2-/- or NOD2-/- bmDCs were incubated for 1 h with GBS wild-type (WT) strains or their respective non-encapsulated (DcpsE) mutants (106 CFU/ml, initial MOI:1). Internalized bacteria were enumerated by quantitative plating after 1 h of antibiotic treatment to kill extracellular bacteria (n55).

References Powered by Scopus

Pathogen recognition and innate immunity

9781Citations
N/AReaders
Get full text

The role of pattern-recognition receptors in innate immunity: Update on toll-like receptors

7274Citations
N/AReaders
Get full text

Pattern Recognition Receptors and Inflammation

6985Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Group B sStreptococcal maternal colonization and neonatal disease: Molecular mechanisms and preventative approaches

115Citations
N/AReaders
Get full text

Innate receptor activation patterns involving tlr and nlr synergisms in covid-19, ali/ards and sepsis cytokine storms: A review and model making novel predictions and therapeutic suggestions

86Citations
N/AReaders
Get full text

The toll-like receptor radical cycle pathway: A new drug target in immune-related chronic fatigue

45Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Lemire, P., Roy, D., Fittipaldi, N., Okura, M., Takamatsu, D., Bergman, E., & Segura, M. (2014). Implication of TLR- but not of NOD2-signaling pathways in dendritic cell activation by group B streptococcus serotypes III and V. PLoS ONE, 9(12). https://doi.org/10.1371/journal.pone.0113940

Readers over time

‘15‘16‘17‘18‘19‘20‘21‘22‘2300.751.52.253

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 7

70%

Researcher 2

20%

Professor / Associate Prof. 1

10%

Readers' Discipline

Tooltip

Agricultural and Biological Sciences 5

50%

Immunology and Microbiology 3

30%

Medicine and Dentistry 2

20%

Save time finding and organizing research with Mendeley

Sign up for free
0